CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 19  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1316
LYS 10.1316
GLU 20.0259
LEU 30.0103
ARG 40.0127
CYS 50.0104
GLN 60.0066
CYS 70.0042
ILE 80.0112
LYS 90.0224
THR 100.0089
TYR 110.0116
SER 120.0115
LYS 130.0135
PRO 140.0108
PHE 150.0076
HIS 160.0133
PRO 170.0069
LYS 180.0095
PHE 190.0098
ILE 200.0026
LYS 210.0021
GLU 220.0038
LEU 230.0039
ARG 240.0055
VAL 250.0049
ILE 260.0059
GLU 270.0067
SER 280.0086
GLY 290.0105
PRO 300.0308
HIS 310.0093
CYS 320.0111
ALA 330.0163
ASN 340.0066
THR 350.0078
GLU 360.0066
ILE 370.0058
ILE 380.0052
VAL 390.0045
LYS 400.0066
LEU 410.0085
SER 420.0151
ASP 430.0260
GLY 440.0206
ARG 450.0186
GLU 460.0103
LEU 470.0071
CYS 480.0075
LEU 490.0081
ASP 500.0099
PRO 510.0083
LYS 520.0228
GLU 530.0120
ASN 540.0165
TRP 550.0121
VAL 560.0087
GLN 570.0109
ARG 580.0103
VAL 590.0081
VAL 600.0060
GLU 610.0090
LYS 620.0043
PHE 630.0058
LEU 640.0061
LYS 650.0253
ARG 660.0339
ALA 670.0343
GLU 680.0384
ASN 690.0875

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.